Agreement also calls for health service to increase net price it pays for innovative drugs by 25%
The NHS is to pay 25% more for innovative drugs in return for zero tariffs on exports of pharmaceuticals to the US under a deal with Donald Trump’s government.
Industry sources estimate it could cost about £3bn in higher spending on drugs over the next three years but also increase the portion of the NHS budget spent on medicines for diseases such as breast cancer, asthma and motor neurone disease, where innovation is key.
Continue reading...Espace publicitaire · 300×250
